Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erwan Bezard

Showing results (11-20 of 298) with videos related to

Pageof 30
Sort By:
Brain : a Journal of Neurology|February 12, 2015
Could the serotonin theory give rise to a treatment for levodopa-induced dyskinesia in Parkinson's disease?Erwan Bezard, Manolo Carta
Movement Disorders : Official Journal of the Movement Disorder Society|June 1, 2011
A tale on animal models of Parkinson's diseaseErwan Bezard, Serge Przedborski
Parkinsonism & Related Disorders|February 4, 2010
Dopamine receptors and L-dopa-induced dyskinesiaAmandine Berthet, Erwan Bezard
Experimental Neurology|October 2, 2007
Preclinical development of gene therapy for Parkinson's diseaseGrégory Porras, Erwan Bezard
Brain : a Journal of Neurology|October 31, 2019
Intrastriatal injection of alpha-synuclein fibrils induces Parkinson-like pathology in macaquesBenjamin Dehay, Erwan Bezard
Medecine Sciences : M/S|January 21, 2022
[Aggregation and spread of synuclein in Parkinson's disease]Erwan Bezard, Benjamin Dehay
International Review of Neurobiology|September 13, 2011
Molecular mechanisms of l-DOPA-induced dyskinesiaGilberto Fisone, Erwan Bezard
Parkinsonism & Related Disorders|January 20, 2010
Involvement of canonical and non-canonical D1 dopamine receptor signalling pathways in L-dopa-induced dyskinesiaCéline Guigoni, Erwan Bezard
Animal Models and Experimental Medicine|April 25, 2019
Local transgene expression and whole-body transgenesis to model brain diseases in nonhuman primateLucie Chansel-Debordeaux, Erwan Bezard
Neurobiology of Disease|August 20, 2013
Neurological drug development: a guide for a start-up biotechThomas P Blackburn, Erwan Bezard
Pageof 30

Showing results (11-20 of 298) with videos related to

Sort By:
Pageof 30
Brain : a Journal of Neurology|February 12, 2015
Could the serotonin theory give rise to a treatment for levodopa-induced dyskinesia in Parkinson's disease?Erwan Bezard, Manolo Carta
Movement Disorders : Official Journal of the Movement Disorder Society|June 1, 2011
A tale on animal models of Parkinson's diseaseErwan Bezard, Serge Przedborski
Parkinsonism & Related Disorders|February 4, 2010
Dopamine receptors and L-dopa-induced dyskinesiaAmandine Berthet, Erwan Bezard
Experimental Neurology|October 2, 2007
Preclinical development of gene therapy for Parkinson's diseaseGrégory Porras, Erwan Bezard
Brain : a Journal of Neurology|October 31, 2019
Intrastriatal injection of alpha-synuclein fibrils induces Parkinson-like pathology in macaquesBenjamin Dehay, Erwan Bezard
Medecine Sciences : M/S|January 21, 2022
[Aggregation and spread of synuclein in Parkinson's disease]Erwan Bezard, Benjamin Dehay
International Review of Neurobiology|September 13, 2011
Molecular mechanisms of l-DOPA-induced dyskinesiaGilberto Fisone, Erwan Bezard
Parkinsonism & Related Disorders|January 20, 2010
Involvement of canonical and non-canonical D1 dopamine receptor signalling pathways in L-dopa-induced dyskinesiaCéline Guigoni, Erwan Bezard
Animal Models and Experimental Medicine|April 25, 2019
Local transgene expression and whole-body transgenesis to model brain diseases in nonhuman primateLucie Chansel-Debordeaux, Erwan Bezard
Neurobiology of Disease|August 20, 2013
Neurological drug development: a guide for a start-up biotechThomas P Blackburn, Erwan Bezard
Pageof 30